Revenue

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.

Couples are now using Valentine's Day to plan luxury destination weddings, with immersive pre-wedding trips to places like Switzerland gaining popularity.

Las Vegas Sands names Patrick Dumont CEO, signaling a new chapter focused on executing massive multi-billion dollar investments in Macao and Singapore.

A new online pharmacy is challenging the 'prescribe and forget' model for weight loss drugs, offering integrated clinical care to combat safety concerns.

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.

With 15 'Best Bank' awards fueled by client feedback and record SBA lending, Huntington Bank demonstrates a winning formula for business banking success.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

Alto Neuroscience completes enrollment for a trial of its skin patch drug, ALTO-101, offering new hope for the millions battling cognitive decline in schizophrenia.

A $1.1 billion joint venture in Kazakhstan is set to develop the world's largest tungsten reserve, challenging China's dominance in a critical mineral.

A new software upgrade uses AI to make low-cost drones perform like high-end systems, a breakthrough with major implications for defense and industry.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

In a major strategic shift, Matthews Asia's founders are buying back control, reinforcing the firm's independent identity and hiring a top China expert.

Irish firm InVera Medical wins CE Mark for a new varicose vein device, promising a less invasive, office-based treatment for a widespread condition.

Comparor launches its AI assistant, joining a tech race to simplify shopping and find the best price. But what does this mean for you and for retailers?

The uranium giant posted a massive jump in 2025 earnings, fueled by strategic investments and a global rush for clean, secure energy. Here's what's next.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

Applied Optoelectronics breaks ground on a massive Texas facility, aiming to secure the domestic supply chain for the critical components powering America's AI boom.

The pipeline giant's record $20B EBITDA is fueled by traditional energy, while it aggressively expands into renewables to power the digital economy.

New integration promises to slash response times by unifying leads in one inbox. Here’s why it’s a game-changer for local businesses and customer acquisition.